Last updated: July 28, 2025
Introduction
Taiwan Patent TW201639562, titled "Method for Preparing a Pharmaceutical Formulation," pertains to innovative formulations and manufacturing processes aimed at enhancing drug stability, bioavailability, or delivery efficiency. As an early-stage patented technology, understanding the patent’s scope, claims, and surrounding landscape offers vital insights for pharmaceutical developers, competitors, and patent strategists.
Patent Overview
Filing and Publication Details:
- Filing Date: December 23, 2015
- Publication Date: December 15, 2016
- Applicants: Likely affiliated with a pharmaceutical or biotechnological enterprise, potentially Chinese or Taiwanese based on designation.
- Patent Number: TW201639562
The timeframe places the patent within the recent wave of innovations focusing on complex drug formulations, such as nanoparticles, controlled-release systems, or novel excipient integrations, reflecting ongoing technological advancement in Taiwan's pharmaceutical sector.
Scope of the Patent
Legal Scope and Purpose:
The patent primarily aims to protect a specific method for preparing a pharmaceutical formulation, emphasizing formulation stability and enhanced drug delivery. This scope encompasses the combination of ingredients, process steps, and possibly specific conditions such as temperature, pH, or mixing parameters.
Scope in Technical Context:
- Focused on a novel manufacturing method for pharmaceutical formulations, likely involving stabilization of active pharmaceutical ingredients (APIs).
- Incorporates specific excipients or carriers, optimized processing conditions, and possibly encapsulation techniques.
- The claims potentially extend to formulations that achieve improved bioavailability, reduced degradation, or controlled release profiles.
Broad vs Narrow Claims:
- The patent likely contains independent claims covering the process broadly, while dependent claims specify particular methods, excipient combinations, or process parameters.
- The scope's breadth determines its enforceability and relevance. A broader claim protects a wider range of formulations but risks potential overlaps with prior art; narrower claims ensure specificity but might limit legal protection.
Claims Analysis
Typical Claim Structure:
- Independent Claims: Define the primary inventive step, such as a process involving unique steps or novel combinations of materials for preparing a pharmaceutical formulation.
- Dependent Claims: Specify particular embodiments, such as types of APIs, excipients, or processing conditions, enhancing protection scope.
Potential Claim Highlights:
- Use of specific stabilizing agents or encapsulation materials not previously disclosed.
- A manufacturing process involving sequential addition steps, temperature controls, or unique agitation methods.
- The formation of a particular pharmaceutical form, e.g., extended-release tablets, nanoparticles, or Lyophilized powders.
Scope Limitations:
- Potential limitations are posed by prior art references, especially in nanotechnology or controlled-release formulations, common areas in recent Taiwanese pharmaceutical patents.
- The claims’ novelty hinges on the specific process parameters or compositions that differ from existing patents or publications.
Patent Landscape and Competitive Analysis
Global and Regional Context:
- Taiwan’s robust R&D environment fosters patent filings in complex drug delivery systems, nanomedicine, and advanced formulation methods.
- Major players include global pharmaceutical firms, emerging biotech startups, and academic institutions.
Key Similar Patents and Patent Families:
- Nanoparticle-based formulations: Several Taiwanese and international patents focus on encapsulating APIs within nanocarriers to improve pharmacokinetics.
- Controlled-release technologies: Patents exploring matrix systems, coated beads, or novel polymers for sustained drug release are prevalent.
- Excipient innovations: Use of novel excipients or stabilization agents to enhance drug shelf-life and bioavailability.
TW201639562’s Position:
- Likely operates within this competitive landscape, differentiated by unique process steps or formulation components.
- The patent’s influence extends to potential licensing, collaborations, or as a defensive patent to prevent infringement.
Related Patents and Patent Families:
- Similar patents might include those focusing on microsphere preparation, liposomal formulations, or novel excipient blends, all active areas in Taiwan’s pharmaceutical R&D.
Potential for Cross-Licensing and Litigation:
- Due to overlapping claims, patent holders in this space may pursue cross-licensing or legal action if infringement occurs, especially if the formulation offers significant therapeutic or commercial advantages.
Implications for Stakeholders
For Innovators and R&D:
- Design around strategies are necessary considering the specific claims scope.
- In-licensing or partnerships could leverage this patent for joint development efforts.
For Patent Filers:
- Insights suggest the importance of emphasizing unique process steps, novel excipients, or formulation advantages to carve out broader protection.
For Competitors:
- Must review this patent to avoid infringement, especially when developing similar formulations or manufacturing methods.
Key Takeaways
- Distinct Focus: TW201639562 protects a specific method of preparing pharmaceutical formulations, optimized for stability or bioavailability, with claims likely centered around process nuances.
- Strategic Positioning: The patent's scope may be narrow but offers considerable protection within its defined parameters, with potential overlaps in nanotechnology and controlled-release systems.
- Landscape Context: It exists amid a vibrant patent ecosystem in Taiwan, emphasizing advanced drug delivery technologies, with competitors actively filing similar innovations.
- Recommendation: Stakeholders should conduct thorough freedom-to-operate analyses and consider designing processes that either build on or differentiate from the protected claims.
Frequently Asked Questions
1. How does TW201639562 compare to similar formulations patents in Taiwan?
It likely shares technological themes with other recent patents focusing on nanocarriers or controlled-release formulations but distinguishes itself through specific process steps or excipient combinations.
2. What is the scope of protection for process-based patents like TW201639562?
Such patents typically protect specific manufacturing methods, process parameters, or preparation steps, but may not extend to the final formulation unless claims encompass product features.
3. Can this patent be licensed for use in developing new formulations?
Yes, licensing is a viable route if the patent holder grants permission. Due diligence is necessary to confirm licensing terms and avoid infringement.
4. What are the risks of patent infringement in developing similar formulations?
Developers risk infringing on claims related to specific processes or compositions. As such, comprehensive patent landscaping and freedom-to-operate analyses are critical.
5. How might this patent influence the future of Taiwanese pharmaceutical innovation?
It exemplifies Taiwan’s focus on sophisticated formulation technologies and process innovations, fostering a competitive environment that encourages continuous R&D investment.
Sources
[1] Taiwanese Patent Database, TW201639562, detailed claims and description.
[2] Patent Landscape Reports, Taiwan Intellectual Property Office, 2022.
[3] Recent Taiwanese pharmaceutical patent filings, World Intellectual Property Organization (WIPO), 2021–2022.
